Myeloma: The Role of Interleukin 6

Durie BM . The biology of multiple myeloma. Haemat Oncol 1988; 6: 77–81.

Barlogie B Epstein J Selvanayagam P Alexanian R . Plasma cell myeloma - new biological insights and advances in therapy. Blood; 1989; 73: 865–79.

Zhang X-G Klein B Bataille R . Interleukin 6 is a potent myeloma cell growth factor in patients with aggressive multiple myeloma. Blood 1989; 74: 111–13.

Klein B Zhang X-G Jourdan M Bataille R . Paracrine rather than autocrine regulation of myeloma cell growth and differentiation by Interleukin 6. Blood 1989; 73: 517–26.

Epstein J Petrucci MT Hata H Woodliff J . Indications of concurrent autocrine and paracrine cytokine loops in multiple myeloma suggest only a secondary role for IL-6. In: Pileri A , ed. Multiple myeloma from biology to therapy abstracts of IIIrd International Workshop. Boccadoro, 1991:45–47.

Klein B Zhang X-G Jourdan M Bataille R . GM-CSF synergises with IL-6 in supporting the proliferation of human myeloma cells. Blood 1989; 74(suppl 1a): 749.

Bergui L Schena M Gaidano G Riva M Caligaris-Cappio F . Interleukin 3 and Interleukin 6 synergistically promote the proliferation and differentiation of malignant plasma cells and their precursors in multiple myeloma. J Exper Med 1989; 170: 613–18.

Jernberg H Petterson M Kishimoto T Nilsson K . Heterogeneity in response to Interleukin 6 (IL6), expression of IL6, and IL6 receptor mRMA in a panel of established human multiple myeloma cell lines. Leukaemia 1991; 5: 255–65.